Insights on Life Sciences
Article
Reimagining life science enterprises with agentic AI
-
Agentic AI is poised to boost the benefits from AI by changing its role from tool to coworker and catalyzing an end-to-end reimagining of the life sciences value chain.
Article
The emerging epicenter: Asia’s role in biopharma’s future
-
Asia is now the epicenter of global biopharmaceutical progress—outpacing the United States and Europe in pipeline growth,...
Article
Clear, credible, compelling: Mastering investor engagement in life sciences
-
Life sciences’ long R&D cycles and high stakes can test market confidence. Companies that excel at six engagement essentials...
Report
Shaping the future of India’s pharmaceutical operations
-
India, the world’s largest producer of generic medicines, faces major technological and geopolitical disruptions. Eight...
Podcast
Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
-
Bristol Myers Squibb Chief Digital and Technology Officer Greg Meyers on how AI is helping biopharma move faster, experiment...
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.